Cargando…

Anticancer Drug Conjugates Incorporating Estrogen Receptor Ligands

Hormone-dependent cancers, such as certain types of breast cancer are characterized by over-expression of estrogen receptors (ERs). Anticancer drug conjugates combining ER ligands with other classes of anticancer agents may not only benefit from dual action at both anti-cancer targets but also from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zlotos, Darius P., Kronenberger, Thales, Laufer, Stefan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866829/ https://www.ncbi.nlm.nih.gov/pubmed/36678697 http://dx.doi.org/10.3390/pharmaceutics15010067

Ejemplares similares

COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
por: Kronenberger, Thales, et al.
Publicado: (2023)

Drug conjugates—an emerging approach to treat breast cancer
por: Hasan, Mahmud, et al.
Publicado: (2018)

Dual PARP and RAD51 Inhibitory Drug Conjugates Show Synergistic and Selective Effects on Breast Cancer Cells
por: Malka, Matthews M., et al.
Publicado: (2021)

Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
por: Komm, Barry S, et al.
Publicado: (2012)

Design, Synthesis and Biochemical Evaluation of Novel Selective Estrogen Receptor Ligand Conjugates Incorporating an Endoxifen-Combretastatin Hybrid Scaffold
por: Keely, Niall O., et al.
Publicado: (2016)

Novel Selective Estrogen Receptor Ligand Conjugates Incorporating Endoxifen-Combretastatin and Cyclofenil-Combretastatin Hybrid Scaffolds: Synthesis and Biochemical Evaluation
por: Kelly, Patrick M., et al.
Publicado: (2017)

Anticancer nanoparticulate polymer‐drug conjugate
por: Feng, Quanyou, et al.
Publicado: (2016)

Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive antagonist
por: Rashidian, Azam, et al.
Publicado: (2022)

Discovery of Novel CCR5 Ligands as Anticolorectal Cancer Agents by Sequential Virtual Screening
por: El-Zohairy, Mariam A., et al.
Publicado: (2021)

Estrogen Receptor Ligands: A Review (2013–2015)
por: Farzaneh, Shabnam, et al.
Publicado: (2016)

Computer-Aided Ligand Discovery for Estrogen Receptor Alpha
por: Bafna, Divya, et al.
Publicado: (2020)

Estrogen receptor transcription and transactivation: Structure-function relationship in DNA- and ligand-binding domains of estrogen receptors
por: Ruff, Marc, et al.
Publicado: (2000)

Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates
por: Kalim, Muhammad, et al.
Publicado: (2017)

Versatility or Promiscuity: The Estrogen Receptors, Control of Ligand Selectivity and an Update on Subtype Selective Ligands
por: Ng, Hui Wen, et al.
Publicado: (2014)

Gefitinib conjugated PEG passivated graphene quantum dots incorporated PLA microspheres for targeted anticancer drug delivery
por: Gautam, Abhishek, et al.
Publicado: (2022)

Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA)
por: Taguchi, Yasuto, et al.
Publicado: (2004)

Immunotoxins and Anticancer Drug Conjugate Assemblies: The Role of the Linkage between Components
por: Dosio, Franco, et al.
Publicado: (2011)

Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity
por: Georgiadis, Markos-Orestis, et al.
Publicado: (2017)

Discovery of Polyphenolic Natural Products as SARS-CoV-2 M(pro) Inhibitors for COVID-19
por: Krüger, Nadine, et al.
Publicado: (2023)

Semisynthetic Analogues of Toxiferine I and Their Pharmacological Properties at α7 nAChRs, Muscle-Type nAChRs, and the Allosteric Binding Site of Muscarinic M(2) Receptors
por: Zlotos, Darius P., et al.
Publicado: (2014)

SPIONs Conjugate Supported Anticancer Drug Doxorubicin’s Delivery: Current Status, Challenges, and Prospects
por: Akhtar, Naseem, et al.
Publicado: (2022)

The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause
por: Lello, Stefano, et al.
Publicado: (2017)

Crystal structure of 5,11-dihydropyrido[2,3-b][1,4]benzodiazepin-6-one
por: Riad, Noura M., et al.
Publicado: (2015)

Exploiting Ligand-Protein Conjugates to Monitor Ligand-Receptor Interactions
por: Haruki, Hirohito, et al.
Publicado: (2012)

Estrogen receptor transcription and transactivation: Basic aspects of estrogen action
por: Nilsson , Stefan, et al.
Publicado: (2000)

Glutathione-Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation
por: Potęga, Agnieszka
Publicado: (2022)

Molecular Modeling Applied to Nucleic Acid-Based Molecule Development
por: Krüger, Arne, et al.
Publicado: (2018)

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000)

Ligand‐ and Structure‐Based Approaches of Escherichia coli FabI Inhibition by Triclosan Derivatives: From Chemical Similarity to Protein Dynamics Influence
por: Kronenberger, Thales, et al.
Publicado: (2019)

Ligand Accessibility Insights to the Dengue Virus NS3‐NS2B Protease Assessed by Long‐Timescale Molecular Dynamics Simulations
por: Kronenberger, Thales, et al.
Publicado: (2021)

Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs
por: Negi, Arvind, et al.
Publicado: (2022)

Gemcitabine-incorporated polyurethane films for controlled release of an anticancer drug
por: Choi, Seong Hoon, et al.
Publicado: (2019)

Structural and Functional Profiling of Environmental Ligands for Estrogen Receptors
por: Delfosse, Vanessa, et al.
Publicado: (2014)

New spectrofluorimetric methods for determination of melatonin in the presence of N-{2-[1-({3-[2-(acetylamino)ethyl]-5-methoxy-1H-indol-2-yl}methyl)-5-methoxy-1H-indol-3-yl]- ethyl}acetamide: a contaminant in commercial melatonin preparations
por: Darwish, Hany W., et al.
Publicado: (2012)

Erratum to: New spectrofluorimetric methods for determination of melatonin in the presence of N-{2-[1-({3-[2-(acetylamino)ethyl]-5-methoxy-1H-indol-2-yl}methyl)-5-methoxy-1H-indol-3-yl]-ethyl}acetamide: a contaminant in commercial melatonin preparations
por: Darwish, Hany W., et al.
Publicado: (2016)

Transactivation Function-1-Mediated Partial Agonist Activity of Selective Estrogen Receptor Modulator Requires Homo-Dimerization of the Estrogen Receptor α Ligand Binding Domain
por: Arao, Yukitomo, et al.
Publicado: (2019)

Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
por: Rossini, Maurizio, et al.
Publicado: (2013)

CC Chemokine Ligand-2: A Promising Target for Overcoming Anticancer Drug Resistance
por: Shi, Zhenbo, et al.
Publicado: (2022)

Estrogen, Estrogen Receptor and Lung Cancer
por: Hsu, Li-Han, et al.
Publicado: (2017)

Predictive features of ligand‐specific signaling through the estrogen receptor
por: Nwachukwu, Jerome C, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mplinadebqtei7tqpf3k3gjgso